	Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2Aâ€‘rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial. Lancet Haematol Hu Z, Fan Z, Dai M, He H, Jin H, Sun Z, Huang F, Xu N, Liu Q, Li Y, Dong Y, Zhu P, Liu C, Zeng Y, Sun J, Sun R, Xuan L, Liu Q. PMID: 42956759 [PubMed - indexed for MEDLINE]
	Translating Translation: Lessons from Zotatifin's Clinical Development and the Case for Trials in Lymphoma. Curr Oncol Rep Manara P, Schatz JH. PMID: 42955527 [PubMed - indexed for MEDLINE]
	Real-world outcomes of glofitamab monotherapy in heavily pretreated patients with relapsed/refractory diffuse large B-cell lymphoma: A multicenter Korean cohort. Ann Hematol Kim C, Koh Y, Jeon Y, Choi YS, Kim SJ, Kim WS, Yoon SE. PMID: 42955341 [PubMed - indexed for MEDLINE]
	The Evolving Landscape of Reduced-Intensity Conditioning: Balancing Efficacy and Toxicity Across Hematologic Malignancies. Curr Hematol Malig Rep Chumnumsiriwath P, Ciurea SO, Kongtim P. PMID: 42955162 [PubMed - indexed for MEDLINE]
	Treatment-free remission after bosutinib discontinuation (BOSUTFR): results from a multicenter real-world study by the Spanish CML group. Ann Hematol De Paz Arias R, Maortua Langdon G, Stuckey R, Giraldo P, Xicoy B, Martínez López J, Bautista G, Alonso Alonso JM, Noya MS, Sierra M, de Las Heras N, Pérez López R, Saavedra S, Gómez-García de Soria V, Chen-Liang TH, Santaliestra M, García Gutiérrez V, Spanish CML Group (GELMC). PMID: 42955104 [PubMed - indexed for MEDLINE]
	A Mobile Health Intervention to Reduce Sedentary Behavior Among Adolescents and Early Young Adults Receiving Treatment for Acute Lymphoblastic Leukemia: Protocol for a Single-Arm Feasibility Trial. JMIR Res Protoc Ivory BJ, Chi YY, Belcher BR, Freyer DR. PMID: 42954148 [PubMed - indexed for MEDLINE]
	Corticosteroid response and biopsy decisions in tumefactive demyelination and primary central nervous system lymphoma. Front Immunol Wang X, Guo S. PMID: 42953333 [PubMed - indexed for MEDLINE]
	CD23-negative atypical chronic lymphocytic leukemia with a novel three-way translocation t(4;10;13), unmutated: immunoglobulin heavy chain variable gene, and stereotyped subset #6 (case report). Pan Afr Med J Guaouguaou R, Jebbor A, Lotfi K, Ziani SI. PMID: 42953034 [PubMed - indexed for MEDLINE]
	Research progress on the BAG3-HSP70 axis-mediated autophagy in acute myeloid leukemia. Front Cell Dev Biol Liu Y, Wu T. PMID: 42953017 [PubMed]
	Beta-blocker use and survival in diffuse large B-cell lymphoma: a post hoc analysis of the RICOVER-60 trial. Haematologica Bewarder M, Bewarder Y, Neumann F, Baumann C, Markwirth P, Lesan V, Kos IA, Schormann C, Kiefer M, Kaddu-Mulindwa D, Bittenbring JT, Hohl M, Böhm M, Christofyllakis K, Thurner L. PMID: 42952449 [PubMed - as supplied by publisher]
	Quizartinib in older patients (aged â‰¥60 years) with newly diagnosed FLT3-ITDpositive acute myeloid leukemia: subgroup analyses from QuANTUM-First. Haematologica Montesinos P, Levis MJ, Patkowska E, Cortes J, Perl AE, Sekeres MA, Dombret H, Wang J, Schlenk RF, Liu L, Khan N, Rohrbach JEC, Nahar A, Burns K, Erba HP. PMID: 42952446 [PubMed - as supplied by publisher]
	Time burden and treatment patterns of patients with newly diagnosed acute myeloid leukemia receiving parenteral hypomethylating agents in combination with venetoclax. Leuk Lymphoma Zeidan AM, Zhao R, Voegel A, Christensen D, Zhdanava M, Tardif-Samson A, Vanden Eynde C, Keer H, Pilon D, Sun F. PMID: 42952121 [PubMed - as supplied by publisher]
	Ex Vivo Thrombin Generation Assessment of Four Anticoagulants in Children with Acute Lymphoblastic Leukemia. Pediatr Hematol Oncol Leader A, Wolach O, Gavrieli B, Elitzur S, Spronk HMH, Nagy M, van Oerle R, Spectre G, Shimony S, Moshe Y, Mahajna R, Martin L, Gilad G, Gilead O, Avrahami G, Izraeli S, Raanani P, Barzilai-Birenboim S. PMID: 42952116 [PubMed - as supplied by publisher]
	An Exploratory Study of Fusion of Intratumoral and Peritumoral Ultrasound Radiomics With Clinical Features for Distinguishing Diffuse Large B-Cell Lymphoma From Hodgkin Lymphoma. Ultrasound Med Biol Yi L, Wang J, Li X, He L, Liu L. PMID: 42951791 [PubMed - as supplied by publisher]
	SOHO State of the Art Updates and Next Questions \| Best of Cell Therapy for Lymphoma. Clin Lymphoma Myeloma Leuk Alharthy H, Ahmed S. PMID: 42951739 [PubMed - as supplied by publisher]
	Unilateral myositis: a diagnostic dilemma revealing anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Intern Med J van Staden A, Wrenford A, Jones A. PMID: 42951681 [PubMed - as supplied by publisher]
	IDH2 p.R172 mutation Predicts Superior Outcomes in IDH-mutated Acute Myeloid Leukemia or Myelodysplastic Syndrome patients undergoing Allogeneic Hematopoietic Cell Transplantation: a retrospective study from the Grupo EspaÃ±ol de Trasplante HematopoyÃ©tico y Terapia Celular (GETH-TC). Transplant Cell Ther Pérez-González A, Navarro V, Guerreiro M, Villalba M, Avendaño A, Pérez-López E, González-Rodríguez AP, Mussetti A, Parody R, Kwon M, García-Cadenas I, Zudaire T, Bandres E, López-Godino O, Delgado I, Díez-Campelo M, Salamero O, Balsalobre P, Bosch F, Valcárcel D, Cascón MJP, Ortí G, Grupo Español de Trasplantes hematopoyéticos y Terapia Celular (GETH-TC). PMID: 42951113 [PubMed - as supplied by publisher]
	Oral Cryotherapy for Prevention of Oral Mucositis Following High-Dose Methotrexate in Children With Acute Lymphoblastic Leukemia: A Randomized Controlled Study. J Pediatr Hematol Oncol Kaul SA, Arora SK, Attri K, Hemal A. PMID: 42950282 [PubMed - as supplied by publisher]
	Omission of Radiation Therapy is Associated with Inferior Disease Control in High Risk Early-Stage Hodgkin Lymphoma. Blood Adv Dave NK, Dreyfuss AD, Moskowitz AJ, Yahalom J, Alfaro MKC, Birrer N, Hu B, Koch R, Frosch ZA, Colton M, Ho C, Amoozgar B, Feldman TA, Saxena A, Rhodes JM, Dunton A, Shah NN, Mantione A, Hubbeling H, LaRiviere MJ, Plastaras JP, Fregonese B, Imber BS, Muenzen RM, Barta SK, Carter J, Chong EA, Cook M, Landsburg DJ, Nasta SD, Schuster SJ, Thomas CJ, Tomasulo E, Svoboda J. PMID: 42950253 [PubMed - as supplied by publisher]
	Treatment patterns and healthcare utilization for patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL) in the Veterans Health Administration (MCLOVA) who were prescribed their first Bruton Tyrosine Kinase inhibitor (BTKi): A national retrospective cohort study. J Oncol Pharm Pract Ogbeifun H, Gilmore CM, Nooruddin ZI, Kaur S, Nguyen CL, Vargus A, Koeller J, Smelter DF, Teng C, Franklin K, Jones XF, Frei CR. PMID: 42949506 [PubMed - as supplied by publisher]

Articles 1 - 20 / 171077

Page 1 of 8554



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy